Back to search

Article

Investigating simultaneous effect of CCR3 Receptor Antagonist therapy and Mesenchymal Stem Cells (MSC) transduced with eosinophil suppressor tetrapeptide protein, SP-A as cell therapy in Allergic Asthma​

2026-06-19

Abstract excerpt

<title>Abstract</title> <p>Allergic asthma is an important global health challenge and characterized by a type 2 inflammatory response. Allergic asthma has no certain treatment and novel therapeutic strategies are needed. The main orchestration of asthma is eosinophil, which for recruitment and activation dependences CCR3. Concurrently, stem cell-based therapies, and enhanced therapeutic efficacy with genetic eng...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9d1e385-0c65-5f4e-8202-952fad2632d3
DOI
10.21203/rs.3.rs-9509928/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigating simultaneous effect of CCR3 Receptor Antagonist therapy and Mesenchymal Stem Cells (MSC) transduced with eosinophil suppressor tetrapeptide protein, SP-A as cell therapy in Allergic Asthma​DOI 10.21203/rs.3.rs-9509928/v1
Select a neighboring publication to make it the new centre.